Venrock Healthcare Capital Partners III, L.P. → X4 Pharmaceuticals, Inc. XFOR

Stake: — Shares: — Class: Common Stock, $0.001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 6.04

7,590,000 shares short · -7.8% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $3.23M

Point72 Asset Mgmt

Other 13D/G Filings on X4 Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2019-07-17	SC	Polaris Venture Partners V, L.P.	—	—	view →
2019-05-28	SC	New Enterprise Associates 16, L.P.	—	—	view →
2019-03-19	SC	ORBIMED ADVISORS LLC	—	—	view →
2018-01-26	SC	ORBIMED ADVISORS LLC	—	—	view →

Other Filings by Venrock Healthcare Capital Partners III, L.P.

Filed	Form	Issuer	Stake	Shares
2026-09-15	SCHEDULE 13D	Korsana Biosciences, Inc.	9.90%	4,552,277	view →
2026-09-08	SCHEDULE 13D/A	APOGEE THERAPEUTICS, INC.	—	0	view →
2026-06-09	SCHEDULE 13G	Relmada Therapeutics, Inc. RLMD	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →